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Abstract  
 
Objective: Increasing numbers of people are expected to live with comorbid cancer 
and dementia. Cancer treatment decision-making for these individuals is complex, 
particularly for those lacking capacity, requiring support across the cancer care 
pathway. There is little research to inform practice in this area. This ethnographic 
study reports on the cancer decision-making experiences of people with cancer and 
dementia, their families, and healthcare staff.  
Methods: Participant observations, informal conversations, semi-structured 
interviews, and medical note review, in two NHS trusts. Seventeen people with 
dementia and cancer, 22 relatives and 19 staff members participated.  
Results: Decision-making raised complex ethical dilemmas and challenges and raised 
concerns for families and staff around whether correct decisions had been made. 
Whose decision it was and to what extent a person with dementia and cancer was 
able to make decisions was complex, requiring careful and ongoing consultation and 
close involvement of relatives. The potential impact dementia might have on 
treatment understanding and toleration required additional consideration by 
clinicians when evaluating treatment options.  
Conclusions: Cancer treatment decision-making for people with dementia is 
challenging, should be an ongoing process and has emotional impacts for the 
individual, relatives, and staff. Longer, flexible, and additional appointments may be 
required to support decision-making by people with cancer and dementia. Evidence-
based decision-making guidance on how dementia impacts cancer prognosis, 
treatment adherence and efficacy is required.  
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Background 
Increasing numbers of people are expected to live with comorbid cancer and 
dementia (CCD),1 in a recent review estimates of the size of this population varied 
widely, at up to 45% for some cancer groups.2 Care of people with CCD may be more 
complex than other in populations.  
People with dementia experience later cancer diagnosis, increased likelihood of 
treatment complications, and poorer survival rates.1 They receive less treatment 
than those without dementia.1,2,3 Individuals with dementia and their relatives may 
not disclose memory problems, and oncology clinicians may not ask about 
dementia,5 meaning the implications of dementia for cancer treatment may be 
poorly understood. 
Decision-making in cancer care and treatment is complex, requiring factors including 
age and comorbidities to be balanced with patient preferences, and treatment and 
prognosis expectations6. Many people with cancer experience decision-making 
uncertainty regarding treatment options, not fully understanding treatment intent or 
prognosis6.  However, comprehension and decision-making abilities may be further 
decreased in people with dementia4. 
 
Few studies have specifically considered the role of decision-making in cancer care 
for people with dementia7 and their limitations include single site studies4,5,8 small-
scale samples 4,8, inclusion of people with Mild Cognitive Impairment as well as 
dementia5 and only including staff perspectives.4 The studies to date identify the 
central role of families in decision-making9, with people with dementia often 
depending on them to speak and make decisions on their behalf6,8. Clinicians who 
support decision-making may have different priorities to the person with CCD, and 
their beliefs and understanding about dementia can impact advice given and the 
treatments offered, meaning people with CCD can experience a power imbalance 
and lack of autonomy around treatment decisions.4 Treatment decision-making for 
people with CCD is complex, particularly for those lacking capacity.8 Relatives are 
integral in supporting decision-making, but often have unmet information needs and 
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feel excluded from the process8. Reviews conclude decision-making in CCD remains 
under-researched,8 particularly regarding treatment goals in palliative and end-of-
life decision-making.2 
 
This paper explores cancer treatment decision-making in CCD as one theme 
identified within a larger UK study exploring cancer care experiences of people with 
CCD, their families, and healthcare staff.9  
 
Methods 
Design 
An ethnographic approach was taken, consisting of participant observations, 
informal conversations, semi-structured interviews, and medical note review. 
Setting 
Oncology and associated departments in two National Health Service (NHS) Trusts in 
one UK region and their local communities. 
Procedure 
Ethical approval was gained from the Bradford Leeds Research Ethics Committee 
[243475]. 
In NHS Trusts, staff members (i.e. nurse, consultant) identified and approached 
participants at post-diagnostic clinic appointment to establish interest in speaking to 
a researcher about the study. Study adverts were also shared with local community 
support groups and via social media.  
Written informed consent was obtained for interviews and in-depth observations 
from all participants with capacity, with advice provided by a consultee for people 
lacking capacity12. Ongoing consent was established prior to each observation.  
Participants 
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Participants were people with a diagnosis or suspected dementia (assessed via 
completion of the FAST11) of any type, (mild to moderate severity), who were 
receiving/had recently received cancer treatment; relatives of people with CCD who 
had currently/previously received cancer treatment; and oncology staff with 
experience of supporting people with CCD. Purposive sampling was used to recruit a 
range of staff roles. 
Data collection 
Researchers observed oncology appointments including consultations, treatment, 
and follow-up. Participants were typically met in reception areas to observe their 
entire hospital visit, during which informal conversations were also held, and 
documented within field notes. Semi-structured interviews focused on experiences 
of cancer care for people with CCD and were conducted in their home or a quiet 
hospital room. Interview topic guides were developed with the Lay Advisory Group. 
People with CCD and their relatives were interviewed individually, or as a 
dyad/group, depending on preference. Interviews were audio recorded and 
transcribed verbatim. Participants with CCD currently being treated at participating 
hospitals could opt to participate in an interview and/or observations. Medical notes 
were reviewed for any mention of dementia or associated issues. (See Supporting 
Information 1 for more information on participants and procedure). 
Data Analysis 
Analysis was an iterative process exploring content and patterns in the data via 
triangulation across sources. Initial coding of interviews and observations was 
conducted independently by AG, RK, CS and FC. Ethnographically informed thematic 
analysis13 was used to develop a coding framework. This was discussed and refined 
with the wider research team, including lay members. Data collection and analysis 
ran concurrently, with early analysis informing subsequent data collection. 
Results 
Participant characteristics are summarised in Table 1. Observations and informal 
conversations (totalling 46 hours) were conducted with 12 people with CCD, 8 of 
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whom also participated in interviews, and their families. We conducted 37 
interviews (13 people with CCD, 18 relatives and 19 staff) lasting between 9 and 122 
minutes due to varying communication abilities and participant preference.  
Decision-making challenges were a major theme identified in the data. Not all study 
participants contributed data to each identified theme Within decision-making three 
sub-themes were developed;  
1. Ethical dilemmas and challenges  
2. Whose decision? 
3. Evaluating treatment options 
Ethical dilemmas and challenges 
Decision-making raised complex ethical dilemmas, for example the potentially 
negative impact of people receiving their cancer diagnosis multiple times due to 
short-term memory loss. Staff and relatives experienced uncertainty and sometimes 
conflict over whether this upsetting process was the right thing to do. Thus, 
extended decision-making processes and support were required.  
“You might have told somebody the diagnosis and then you have to tell them 
again and you tell them again and it’s that thing of how fair is it to keep 
telling them? How fair is it then not to tell them?” (L006, Lung Clinical Nurse 
Specialist (CNS)) 
Fluctuating awareness of their diagnosis sometimes meant people with CCD were 
less worried about cancer. For others, however, uncertainty about what was wrong 
caused anxiety.  
“I don’t know what they are going to do with me, that’s what I’m anxious 
about. … I try not to worry about it, because it just upsets me so much. I don’t 
like it. I don’t know what’s happening to my body … I don’t know what to do 
to make myself better and that’s what frightened me.” (L0035, man with 
dementia) 
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Ethical concerns arose when people became distressed receiving cancer treatment. 
Staff questioned whether they were doing the right thing, even though the person 
with dementia had consented and/or it was decided to be in their best interests.  
“It was very, very uncomfortable for all the staff because it’s, “we shouldn’t 
be doing this, because he’s agitated. He’s not liking it.” So, it’s supporting the 
staff, it’s like, “well, if you want me to treat him, I will, because I’ve had the 
long conversation with him and he definitely does want his treatment. He 
knows what he’s letting himself in for” … But that was a bit heart-wrenching 
for staff, because they’re like, it’s not right, we shouldn’t be doing this.” 
(L0042, Patient support practitioner) 
Families sometimes perceived pressure to treat from clinicians and questioned 
whether their relative understood decision implications. 
“That was the big decision to say stop, we’re not going to do anymore 
treatment. Even when he was in the hospice at the end of his life, they still 
wanted to tempt him back for radiotherapy to try and slow things down … he 
said yes, because he didn’t know what it was ... I had to say do you remember 
us going on the train and bus … and then he said I can’t go that far again.” 
(C002, Wife) 
In summary, decision-making raised ethically complex issues and doubts for families 
and clinicians around whether correct decisions had been made. 
Whose decision? 
Responsibility for decision-making was also complex. Understanding and establishing 
whether a person with CCD had capacity to provide consent to cancer treatment 
concerned families and staff. Considerable time and effort could be spent trying to 
ascertain a person’s understanding about treatment options and their implications. 
Where a person lacked capacity, staff typically took care to ensure decisions 
considered relatives’ opinions and the implications of treatments.  
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 “You try and make sure that the whole team agrees this is in the patient’s 
best interest and the patient will be discussed at a multidisciplinary team 
meeting and if there are issues of consent, they’ll be discussed so the whole 
team can suggest alternative ways of dealing with things, or arrange 
additional meetings with the patient and family.” (L0043, Consultant 
oncologist) 
For relatives, decision-making responsibility was stressful and anxiety inducing, 
especially when views and decision-ownership conflicted.  
 “I got really stressed with it, because I thought, everyone will want an input, 
because I’ve got family and they might push saying, well she should have the 
operation, but I’m the one who is the main carer, that sees her nearly every 
day. They see her once a year. But suddenly everyone has got an opinion” 
(L0011, daughter) 
Family and staff generally prioritised inclusion of the person with CCD in decision-
making processes. However, perspectives on the ‘right’ decision did not always align 
and relatives’ views were often influential. When disagreements arose, staff or 
families sometimes questioned whether quality versus quantity of life was 
adequately considered when prioritising treatment. 
 “P1: I said I didn't want the treatment and they [family] more or less said yes 
you should … I said alright I'll have it, but I said no to start with didn't I? 
P2: I think it's not unfair to say that you're not processing the information that 
the Doctor told you and then we've to sit down about it and I asked you what 
you wanted to do and you said well you couldn't remember, so we had to go 
through it again. So, it's not a case of bullying or telling you what to do, but 
guiding you a little bit really.” (L004-5, person with CCD and granddaughter) 
Some relatives reported feeling excluded from decision-making, perceiving 
treatment was administered without their full understanding.  
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“They imposed it. I wouldn’t say I had no choice, but there were no enquiries 
or anything. It was a case of come back and we’ll give her some treatment, 
then half way through, I found out it was radiotherapy.” (L001, husband) 
Other relatives saw clinicians as experts to take the lead on decisions from. 
[Patient] says ‘With no disrespect, it’s slightly going over my head anyway.’ 
[consultant] replies ‘You don’t need to decide today’ [patient] asks ‘How 
important is it, can it wait until after Christmas?’ [grand-daughter] says ‘I think 
if the specialists have looked at it and they recommend it needs doing we 
should take their advice, but it’s up to you’. (Fieldnotes L004-5, person with CCD 
and granddaughter) 
Staff members shared families’ uncertainties around optimal decision-making 
processes when people with CCD lacked decision-making capacity. They sought 
others’ opinions where possible, offering multiple appointments and additional time 
to help families, and sometimes themselves, reach decisions. 
 “She [daughter] would often say, I don’t even know if mum really knows 
what we’re doing here ... But there were a lot of consultations with her 
daughter before she got to surgery.” (B007, Breast CNS) 
In summary, decision-making required careful consideration of capacity issues and 
processes to ensure inclusion of sometimes varied perspectives of all involved and 
uphold the involvement of people with CCD. 
Evaluating treatment options 
Interviewees reported a range of ways in which the additional needs of people with 
CCD were considered within treatment decision-making including the range of 
options available, their ability to cope with these and any resulting side-effects or 
longer-term impacts, and likely prognosis.  ‘Fitness for treatment’ was frequently 
discussed, with concerns here including how well people with dementia might 
tolerate anaesthetic, hormone treatment or chemotherapy. Decisions were more 
complex when cumulative treatments were possible. 
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 “..it’s really difficult when people have memory problems … if there’s a 
choice as well, we might say, you can have local surgery.  But if that shows 
that the disease runs up to the margins, we will need to go back and do more 
surgery and you will also have radiotherapy ... So, you may decide on the 
least invasive treatment, but it comes with the risk of more surgery ... with 
radiotherapy” (B007, Breast CNS) 
Typically, individual ability rather than a dementia diagnosis was prioritised in 
assessing treatment fitness, for example how well individuals would notice side-
effects or tolerate specific treatment requirements.  
 “Chemotherapy side effects can be life threatening ... it’s too high risk, or 
they deem it that way, that if they can’t report what’s wrong with them, if 
they haven’t got the ability to do that, then it would be too dangerous to give 
them the drugs.” (B006 Lung CNS) 
Prognosis was another key consideration, given dementia is life-limiting and many 
patients were older and had other comorbidities.  
“Interviewer: Is there any reason you wouldn’t give someone with dementia a 
certain treatment? 
Participant: I we felt they were dying from the dementia.  … So, if they’re 
quite late onset dementia, and they’re more nursed in bed …” (B005 Lung 
CNS) 
Where treatment would not significantly prolong life, decision-making focused on 
risk-benefit analysis in the context of dementia. For example, where people had no 
symptoms, pain or awareness of their cancer. 
“You don’t want to put somebody at risk because if they’re having palliative 
treatment … chemotherapy for lung cancer potentially only adds three 
months to your life. They can be a very valuable three months, but if that can 
be shortened because you’ve done some harm… it’s got to be that risk versus 
benefit argument.” (B008 Lung CNS)  
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Some decisions were based around how the person might cope with the treatment 
consequences, rather than the treatment itself. For example, coping with being an 
inpatient post-surgery, versus the surgical procedure itself. 
“P2: We were frightened with the operation if she went on to a surgical ward 
… I can just imagine you know .. ‘do you want any breakfast?’ and it’d be ‘no’, 
because she won’t eat, ‘do you want a drink?’, ‘no’, we just had nightmares 
didn’t we, thinking what’s she going to do just laid there, how’s she going to 
go to the toilet because she won’t go up and go.” (B014, daughter) 
In other cases, decisions were determined not on physical treatment experiences or 
consequences, but by potential after effects on memory problems or the potentially 
traumatic treatment impacts. 
 “If they’ve had for instance, a breast removed, they may have forgotten why 
that’s been done. They may feel that they’ve been mutilated against their will 
or wishes. …. So, you’ve got to take that into account when you’re choosing 
what treatments are in the patient’s best interests.” (L0041, Consultant 
Surgeon) 
Whilst many staff actively considered the person’s dementia during decision-making, 
a minority of families felt their relative’s dementia and the ‘bigger picture’ of 
potential treatment impact on their life, was not adequately accounted for.  
 “They discuss hormone therapy, and that it can lead to memory problems. 
[Participant’s] daughter sounds concerned at this ... a little bit more detail is 
given, but it is not clear to what extent this might be an issue. They are told 
that [participant] ‘needs’ the treatment, as if it isn’t an option, so the impact 
on his memory is not an issue for consideration, with the suggestion that they 
start it and see how he gets on” (Field notes, L0039-40, man with CCD and 
daughter) 
In contrast, when the ‘bigger picture’ was considered, clinicians could recognise 
dementia-related concerns, such as the potential impacts of treatment on the 
person due to their dementia.  
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 “They were a bit scared of putting me [under anaesthetic] and then not 
knowing what my reaction was going to be when they’re waking me up.  Am I 
going to be confused?  Am I going to get in to a state because I don’t know 
where I am, what’s happened. Then they said we’ll make an appointment with 
an anaesthetist. He’ll go through things with you and then we’ll decide.” (B009, 
man with CCD) 
Although sometimes these important considerations were initially expressed by 
relatives. 
 “Discussions at MDT suggested to assess suitability for surgery. I saw her 
today and it is her daughter’s opinion, of which I agree, that it would be a 
huge upheaval to bring [participant] into hospital for breast surgery.” (L0011, 
Medical Notes) 
In contrast, on occasion staff had to manage families’ expectations around 
treatments options.  
 “We’d hoped that she might be able to cope with anaesthetic, but she 
couldn’t. Then we looked at giving drug therapies and she wasn’t receptive to 
those either. So, we’ve had to manage expectations for her daughter as well, 
around palliative treatments.” (B008, Breast CNS) 
In summary, dementia did not necessarily reduce treatment options, but was 
considered on an individual basis within the broader context of comorbidity, frailty, 
abilities, impact and prognosis.  
Discussion 
While cancer treatment in older adults often involves ethical dilemmas and complex 
decision-making14, this study provides unique insights into the additional ethical 
challenges comorbid dementia adds and the variety of ways clinicians adapt their 
practice to try and support inclusive decision-making.  
 
It was clear decision-making needed to be an ongoing process and when a decision 
DECISION MAKING FOR PEOPLE WITH DEMENTIA 13 
 
had been made on treatment, this could be reassessed multiple times depending on 
the person’s ongoing medical and personal response to the treatment. Additionally, 
there were specific ethical dilemmas such as the need for continual re-disclosure of a 
cancer diagnosis due to short-term memory problems. Research on diagnosis 
disclosures in dementia15 and cancer16 highlights the need for full, sensitive 
disclosure. However, little research explores cancer diagnosis in the context of 
memory problems and the potential need for repeat disclosures. Ethical challenges 
led to ‘moral distress’ for clinicians, an issue discussed widely in healthcare,17 and 
specifically in oncology literature,18 where the need for ethical guidelines to support-
decision making is highlighted.  Given the current research paucity, practitioners are 
working with little evidence-based guidance to support clinical practice.   
 
Challenges arose when assessing capacity to make informed treatment decisions in 
people with CCD. While patients with cancer at end of life may have reduced 
decision-making capacity19, our study identified that comorbid dementia can affect 
decision-making capacity earlier in the cancer journey, which oncology staff may not 
be prepared or trained to deal with. Assessment of cognitive function is vital during 
decision-making and delivery of cancer care to older people5, to ensure decisions 
made are fully informed, but does not routinely happen in practice10. We found 
relatives were integral to treatment decision-making, supporting reiteration and 
explanation of key information and discussion of treatment options. Previous 
research has highlighted their important role in facilitating inclusion of the person 
with CCD in decision-making4 but has also indicated there may be deference to 
relatives in this process5,8. Our study confirmed these findings and identified the 
considerable burden caused by reliance on families for decision-making. While family 
burden associated with caring for an older person with cancer is well-documented20-
22, the impacts of decision-making have not been highlighted, and our work indicates 
this burden may be greater when someone has CCD. 
Evaluating cancer treatment options was also made more complex by comorbid 
dementia. Whilst cognitive impairment is known to reduce treatment adherence,23 
in our study fitness for treatment, rather than cognitive impairment specifically, 
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informed decisions. Where this ‘bigger picture’ was considered - including the 
impact of a person’s dementia on prognosis, treatment suitability, understanding of 
potentially cumulative treatment options and ability to identify and report side-
effects- shared treatment decisions and plans were able to be made. Again, while 
cancer treatment decisions, particularly in older people, always require 
consideration of an array of complex issues24, dementia brought greater complexity 
and prognostic uncertainty. Geriatric evaluation can prove beneficial in supporting 
decision-making in ?older populations25, however, as these did not arise within the 
data we collected, it was unclear whether these routinely occurred in oncology 
settings.   
Study Limitations 
This study was conducted in one area of the UK, across two NHS Trusts. The 
experiences of people with CCD may vary between hospitals, with further research 
required to validate our results. Triangulation of data sources was not possible for all 
participants and we sometimes relied on retrospective reflections on decision-
making experiences. Although subjectivity is inevitable within ethnographic 
research, we mitigated this by acknowledging our preconceptions before data 
collection began, data being collected by two authors, reflexive journal keeping, 
group data analysis, and synthesis of multiple data sources26. 
Clinical Implications 
Our study has indicated the following implications for oncology practice for people 
with dementia: 
 Treatment decision-making requires additional time and repeated re-
evaluation; longer and/or additional appointments may be required to 
support this; 
 Oncology clinicians may benefit from additional training and support in 
communication with, and assessment of, decision-making capacity in people 
with dementia; 
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 Families play an important role in treatment decision-making and may 
experience additional distress and burden when supporting a person with 
dementia through this. Consideration should be given to how their 
information and support needs can be met within oncology services; 
 Oncology clinicians need to ensure they apply an individualised ability 
focussed assessment, considering the ‘bigger picture’ of how dementia may 
impact cancer treatment options and side-effects, alongside potential longer-
term impacts.  
Conclusions 
Cancer treatment decision-making for people with dementia is complex, challenging 
and fraught with uncertainties, and should be considered as an ongoing process with 
emotional impacts for the individual, relatives, and staff. Oncology clinicians are 
currently working with limited evidence-based guidance on how dementia impacts 
on treatment prognosis, adherence and efficacy. More research is required to 
provide a stronger evidence base for treating people with dementia in oncology 
services. 
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Table 1: Participant demographics (N=58) 
 n (%) 
Participants with CCD (n=17)  
Female 10 (59) 
Cancer type  
Lung 8 (47) 
Prostate 4 (24) 
Breast 1 (6) 
Gastrointestinal 1 (6) 
Other 3 (18) 
Ethnicity 
White British 
Hispanic  
 
16 (94)  
1 (6) 
Age (M,range) (n=13) 75 (45–88) 
  
  
Relatives (n=22)  
Female 14 (64) 
Relationship to participant  
Child 12 (55) 
Spouse 7 (32) 
Sibling 2 (9) 
Grandchild 1 (5) 
 
 
Staff (n=19) 
 
Female 14 (74) 
Role  
         Clinical Nurse Specialist 8 (42) 
         Radiographer 7 (37) 
         Consultant 2 (11) 
         Social worker 1 (5) 
         Patient transport officer 1 (5) 
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Table 2. Themes and sub-themes 
Main Theme Sub Theme 
Ethical dilemmas and challenges were 
raised for families and staff members 
Are we doing the right thing? – staff were 
concerned whether decisions were right 
Whose decision? – balancing decision-
making between different individuals was 
complex 
Capacity and consent issues – perceptions 
of the challenges people with dementia 
faced in making treatment decisions 
Balancing person’s and family wishes – 
ensuring the person with dementia was 
included in decision-making was not always 
straightforward 
Evaluating treatment options presented 
difficulties balancing factors such as 
prognosis and managing side-effects 
What is an option? – staff had to consider 
which options were appropriate for 
patients based on multiple factors 
Balancing and coping with impact of 
treatment – side effects, balancing quality 
and quantity of life, and impact on other 
conditions all had to be considered 
Considering the bigger picture – dementia, 
and the complications that this brings, was 
not always considered  
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